C’mon @BillionGreen give Jackie some credit. After all she is taking a rostered day off from Mirrabooka Investments tomorrow to attend our AGM. Lol.
The only way I will be satisfied with JF and co spending $8m + of our money chasing this nasal spray pipe dream is if JF can negotiate a licencing/distribution deal with a big player with an approx $8m upfront payment to SPL to cover the cost of development. Then it would be a free hit for us regardless of the success or otherwise of the product.
Ann: SPL7013 shows potent antiviral activity in RSV, page-65
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |